| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVAX | Common Stock | Options Exercise | +3.1K | +52.17% | 9.04K | Dec 14, 2022 | Direct | F1, F2, F3 | ||
| transaction | NVAX | Common Stock | Tax liability | -$17.8K | -1.03K | -11.42% | $17.23 | 8.01K | Dec 14, 2022 | Direct | F4, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVAX | Restricted Stock Units | Options Exercise | $0 | -3.1K | -50% | $0.00 | 3.1K | Dec 14, 2022 | Common Stock | 3.1K | Direct | F2, F6 |
| Id | Content |
|---|---|
| F1 | The shares were received by the Reporting Person in connection with vesting of restricted stock units ("RSUs"). |
| F2 | Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| F3 | Includes 278 shares acquired on January 31, 2022 and 1 share acquired on July 31, 2022, each under the Company's Amended and Restated 2013 Employee Stock Purchase Plan, as amended. |
| F4 | The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs. |
| F5 | The shares reported on this Form 4 are subject to a lock-up agreement between the Reporting Person, J.P. Morgan Securities LLC and Jefferies LLC, dated December 14, 2022. |
| F6 | The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date. |